Ilsa M. Coleman
0000-0002-1483-7202
Publication & Citation Trends
Publications
0 total
Abstract B022: LuCaP189.4_CL: a novel 2D model of AR - high, CDK12 - mutant mCRPC suitable for studies of genetic and therapeutic vulnerabilities
Cited by 0
Semantic Scholar
Therapeutic targeting of the eIF4E cap-binding domain reveals control of lineage fate in prostate cancer
Cited by 0
Semantic Scholar
Abstract PR005: Epigenetically Informed Therapeutic Strategies for DNA-Hypomethylated Prostate Cancer
Cited by 0
Semantic Scholar
Abstract PR032: Therapeutic targeting of eIF4E cap-binding domain reveals control of lineage fate in prostate cancer
Cited by 0
Semantic Scholar
Abstract A027: CHK1/2 inhibition with prexasertib reveals therapeutic vulnerabilities in advanced prostate cancer
Cited by 0
Semantic Scholar
Abstract A073: Identification of a potential intermediate cell state in the treatment-induced lineage transition from AR-driven prostate cancer to neuroendocrine prostate cancer
Cited by 0
Semantic Scholar
Deep learning-based non-invasive profiling of tumor transcriptomes from cell-free DNA for precision oncology
Cited by 0
Semantic Scholar
Abstract B072: A novel selective glycolysis inhibitor, SGI-1553, targets adenosine kinase in advanced prostate cancer
Cited by 0
Semantic Scholar
Research Topics
Prostate Cancer Treatment and Research
(502)
Cancer, Lipids, and Metabolism
(146)
Molecular Biology Techniques and Applications
(72)
Advanced Proteomics Techniques and Applications
(69)
Estrogen and related hormone effects
(64)
Affiliations
University of Southern California
American Society of Clinical Oncology
Virginia Mason Medical Center
Sage Bionetworks
Cape Town HVTN Immunology Laboratory / Hutchinson Centre Research Institute of South Africa